-
2023/11/13
Takara Bio Announces "SonuAAV™", a Novel AAV Vector for Efficient Gene Transfer to the Inner Ear Organ.
-
2023/10/12
Construction of the Center for Gene and Cell Processing III, which manufactures mRNA vaccine ingredients and enzymes for mRNA production
-
2023/10/05
Takara Bio Announces Publication of Results from NY-ESO-1・siTCR™ Gene Therapy Study in Clinical Cancer Research
-
2023/10/03
Takara Bio Announces Presentation of Comparability Studies for
CD19 JAK/STAT CAR-T Cell Technology Transfer
-
2023/09/25
Takara Bio enters into a license agreement of RetroNectin®
with Fondazione Telethon ETS
読む Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS